Avoid pushing too hard based solely on reduced pain, respect tissue healing timelines
Timelines vary based on severity, how long symptoms have been present, and whether there are concurrent conditions like autoimmunity or chronic infection
Kanemura T, Tamaoki J, Horii S, Sakai N, Kobayashi K, Isono K, Takeuchi S, Takizawa T
Conclusion: Clinical Translation and Future Perspectives BPC-157 represents a promising investigational peptide with extensive preclinical evidence supporting tissue regeneration, cytoprotection, and healing enhancement across multiple organ systems
This testing can include compounds not on standard panels
Methodology notes for researchers For laboratory-grade GHK-Cu, several methodology considerations recur in the published primary literature and in supplier characterization: Speciation